Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave her headaches so severe they sent her to bed. A week after the third dose, she was at a restaurant with her … Source